| 产品名称： | Rotavirus reassortant |
|---|---|
| 商品货号： | TS213366 |
| Classification： | Reoviridae, Rotavirus |
| Agent： | Rotavirus reassortant |
| Strain： | HD/BRV-1 clone 47-1-1 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Parent viruses (a) human origin strain from child hospitalized with diarrhea and (b) bovine origin strain UK from calf with diarrhea |
| Product Format： | frozen |
| Storage Conditions： | -60°C |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | Shares the characteristics of other members of the rotavirus family. Shares the characteristics of other members of the rotavirus family. |
| Effect on Host： | Yes, in vitro effects: Cytopathic effects (typical rotavirus CPE) in MA104 in vivo effects: unknown effect in vivo |
| Name of Depositor： | NIH/NIAID |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Source： | Parent viruses (a) human origin strain from child hospitalized with diarrhea and (b) bovine origin strain UK from calf with diarrhea |
| References： | Greenberg HB, et al. Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors. US Patent 4,571,385 dated Feb 18 1986 Midthun K, et al. Reassortant rotaviruses as potential live rotavirus vaccine candidates. J. Virol. 53: 949-954, 1985. PubMed: 2983101 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Rotavirus reassortant |
|---|---|
| 商品货号： | TS213366 |
| Classification： | Reoviridae, Rotavirus |
| Agent： | Rotavirus reassortant |
| Strain： | HD/BRV-1 clone 47-1-1 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Parent viruses (a) human origin strain from child hospitalized with diarrhea and (b) bovine origin strain UK from calf with diarrhea |
| Product Format： | frozen |
| Storage Conditions： | -60°C |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | Shares the characteristics of other members of the rotavirus family. Shares the characteristics of other members of the rotavirus family. |
| Effect on Host： | Yes, in vitro effects: Cytopathic effects (typical rotavirus CPE) in MA104 in vivo effects: unknown effect in vivo |
| Name of Depositor： | NIH/NIAID |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Source： | Parent viruses (a) human origin strain from child hospitalized with diarrhea and (b) bovine origin strain UK from calf with diarrhea |
| References： | Greenberg HB, et al. Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors. US Patent 4,571,385 dated Feb 18 1986 Midthun K, et al. Reassortant rotaviruses as potential live rotavirus vaccine candidates. J. Virol. 53: 949-954, 1985. PubMed: 2983101 |
